ClareMedica Health Partners and Beecken Petty O’Keefe & Company Form Partnership With Equity Investment

NEXT STORY
Cardiac Rhythm Management (CRM) Devices Market to Surpass US$ 19,938.3 Mn by 2026, Boston Scientific Corporation and Medtronic Covers Majority of the Share: Fortune Business Insights
PREV STORY
Sanofi : Libtayo® (cemiplimab) approved for advanced cutaneous squamous cell carcinoma in the European Union
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ABLYNX ANNOUNCES BOARD CHANGES

GHENT, Belgium, 7 February 2018 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today ...

author_avatar
NASDAQ Market News

Celldex Reports Fourth Quarter and Year-End 2015 Results

HAMPTON, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported ...

author_avatar
NASDAQ Market News

ASTRAZENECA FURTHER SHARPENS FOCUS THROUGH AGREEMENT WITH GENZYME FOR RARE DISEASE MEDICINE CAPRELSA

AstraZeneca today announced that it has entered into a definitive agreement with Genzyme to ...

author_avatar
NASDAQ Market News